Why its kidney care dominance matters more now for investors 
Transportation problems disrupt dialysis care for patients with kidney failure 
Kidney cancer guidelines published – Healthcare Today 
Improving early detection and treatment of liver cancer 
Bernice’s story highlights B.C.’s new liver transplant guidelines for Indigenous patients 
Is End-Stage Renal Disease Treatment Choices Model Moving the Needle?
A recent JAMA Health Forum study found that the Centers for Medicare & Medicaid Services’ End-Stage Renal Disease Treatment Choices...
Sridhar Vembu asks why babies need Hepatitis B vaccine, gets a lesson in healthcare from The Liver Doc | Trending
Zoho CEO Sridhar Vembu has earned the internet’s disdain by asking why babies need to be vaccinated against Hepatitis B....
Histosonics raises $102M for noninvasive treatment to destroy tumors
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief:...
Northwestern’s next-gen kidney transplant technique keeps patient awake during the procedure
Navigate the healthcare industryHealthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers...
Neoadjuvant Immunotherapy Improves Outcomes in Treatment of High-risk Liver Cancer
Patients diagnosed with liver cancer (hepatocellular carcinoma; HCC) who received immune checkpoint inhibitors (ICIs) before surgery—including those who would not...
FDA Approves Gilead’s Seladelpar For Inflammatory Liver Disease, Acquired Via $4B CymaBay Deal – Gilead Sciences (NASDAQ:GILD)
On Wednesday, the FDA granted accelerated approval for Gilead Sciences, Inc.’s GILD Livdelzi (seladelpar) for primary biliary cholangitis (PBC) in combination with...